InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+2.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by HAMER JOHN, Director. Director active across 1 company, notably AbCellera Biologics Inc.. In total, 4 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €4.7m. Activity tracked since 18 June 2021. The latest transaction was filed on 31 August 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
162,649 shares@ US$16.950.19% mcap50.0% of flowCommon SharesSEC:0001209191-21-054543:0
162,649 shares@ US$16.9550.0% of flowCommon SharesSEC:0001209191-21-054543
5,000,000 shares0Common SharesSEC:0000899243-21-025357
5,000,000 shares0Common SharesSEC:0000899243-21-025357:0
4 of 4 declarations
About HAMER JOHN
John Hamer is a Board Member at AbCellera Biologics Inc. He contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding research and development initiatives. As a board member, he ensures that AbCellera meets its performance and innovation objectives.
